Bavarian Nordic A/S, the only producer of an approved vaccine for monkeypox is currently valued at circa 3.4 billion USD.
I estimate the intrinsic value of Bavarian Nordic is 45 billion USD.
Actually, it is quite possible that monkeypox is transmitted by air, not only via physical contact.
And if the coronavirus is to be an example, the monkeypox could show remarkable resiliency, agility, adaptability and ability to change, mutate to survive.
Since Bavarian Nordic is the only producer of an approved monkeypox vaccine, if monkeypox becomes a global pandemic, which the World health Organization said it actually is the demand for Bavarian Nordic's monkey pox vaccine, namely Jynneos could prove huge.
Which naturally would accrue substantial wealth in the next 3 to 5 years to Bavarian Nordic.
No comments:
Post a Comment